Latest News
Feature
Opioid prescriptions got shorter in 2017
Pharmacy benefits manager reports increased use of drugs to treat opioid dependence.
Feature
Hemophilia A treatment gains approval in Europe
Emicizumab is now approved in Europe and the United States for routine prophylaxis of bleeding episodes in people with factor VIII inhibitors.
Podcasts
MDedge Daily News: High deductibles harm breast cancer care
How high deductibles may lead to harm in breast cancer care.
News
FDA approves tests to screen for tickborne parasite in blood supply
The two new tests will screen whole blood and plasma samples.
From the Journals
Age at time of breast cancer diagnosis differs by race/ethnicity
Age-based screening may not provide equal capture rates for whites, nonwhites.
Conference Coverage
Payers part of the drug-pricing problem, says FDA commissioner
WASHINGTON – FDA Commissioner calls for more competition in biologic products.
Conference Coverage
High efficacy, no safety signals for herpes zoster vaccine post-HSCT
SALT LAKE CITY – The vaccine could offer safe, effective protection against herpes zoster in myeloma patients who are immunosuppressed.
Feature
States strive to curb costs for a crucial – but exorbitant – hemophilia treatment
“There aren’t a lot of options available to Medicaid programs in terms of controlling costs, because we don’t set the initial costs”
Latest News
HCT-CI score may predict mortality for nonmalignant disease
SALT LAKE CITY – The Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) is useful in hematologic malignancies, but it may also be...
From the Journals
Breast cancer care delayed when patients have high deductibles
Women with an employer-mandated switch from a low- to high-deductible health plan had significant delays in diagnostic imaging, biopsy, diagnosis...
From the Journals
Ibrutinib linked to invasive fungal infections
The researchers called for greater awareness of the potential for fungal infection in ibrutinib-treated patients.